Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. Glycomine
BrandsGlycomine

How AI describes Glycomine

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

Glycomine logoGlycomineglycomine.com

Glycomine is developing GLM101, a mannose-1-phosphate replacement therapy for the rare genetic disease PMM2-CDG. The company is currently enrolling participants in a global Phase 2b clinical trial to evaluate the drug's safety and efficacy.

Parse Score

28.9
Strength4/ 100
Reach22/ 100
Authority0/ 100

Work at Glycomine?

Claim this profile for the full report: every prompt where Glycomine appears, who is gaining, and what AI says about you. Claiming is free. Ongoing monitoring is a paid upgrade.

Verified with a work email.

Always know where you stand in AI

Monitor Glycomine